Oxford BioMedica, Nycomed Amersham plc deal

NAM will use OXB's antibody fragments (scFv) to tumor associated antigen OBA-1 to develop imaging agents for detecting a range of tumors. NAM will evaluate a radiolabelled version of the scFv as an im...